
Nitrosamine Impurities in Medicinal Products: Risks and Regulatory Insights
Learn about nitrosamine impurities in medicinal products, their causes, regulatory guidance, and strategies for risk evaluation and mitigation.
Read moreSenior Toxicology Officer
5 articles

Learn about nitrosamine impurities in medicinal products, their causes, regulatory guidance, and strategies for risk evaluation and mitigation.
Read more
Conoce los aprendizajes clave de un caso real de reporte de nitrosaminas. Descubre cómo las farmacéuticas pueden pasar de un enfoque meramente de cumplimiento a una gestión proactiva del riesgo.
Read more
Learn key takeaways from a real-world nitrosamine reporting case. Discover how pharma companies can move from compliance to proactive risk management.
Read more
Conoce las impurezas de las nitrosaminas en los medicamentos, sus causas, las orientaciones normativas y las estrategias para evaluar y mitigar los riesgos.
Read more
Explore essential toxicological monitoring tests, including E&L, Nitrosamine Analysis, and Ames Test, to ensure safety and meet regulatory standards.
Read moreWe use cookies to enhance your experience
We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.